| 注册
首页|期刊导航|中国医学创新|门冬氨酸鸟氨酸治疗肝性脑病40例疗效观察

门冬氨酸鸟氨酸治疗肝性脑病40例疗效观察

吕述华

中国医学创新Issue(32):118-119,2.
中国医学创新Issue(32):118-119,2.DOI:10.3969/j.issn.1674-4985.2013.32.058

门冬氨酸鸟氨酸治疗肝性脑病40例疗效观察

Effect of Ornithine Aspartate in Treatment of 40 Cases of Hepatic Encephalopathy

吕述华1

作者信息

  • 1. 江西省遂川县人民医院 江西 遂川 343900
  • 折叠

摘要

Abstract

Objective:To observe the clinical effect of ornithine aspartate in the treatment of hepatic encephalopathy. Method:40 cases of hepatic encephalopathy from December 2010 to November 2012 in our hospital were randomly divided into treatment group(20 cases)and control group (20 cases). The control group was given routine treatment,the treatment group used ornithine aspartate on the basis of conventional therapy. The level of blood ammonia ,mental changes and the treatment effect of two groups were observed before and after treatment. Result:The total effective rate of the treatment group(95.00%)was better than the control group(70.00%)(P<0.05). The blood nitrogen levels of treatment group before and after treatment compared differences had statistically significant(P<0.05). Conclusion:Ornithine aspartate has certain clinical curative effect in the treatment of hepatic encephalopathy,less adverse reaction,and its appearance is safe,it is worth in the clinical application of hepatic encephalopathy.

关键词

肝性脑病/门冬氨酸鸟氨酸/疗效观察

Key words

Hepatic encephalopathy/Ornithine aspartate/Curative effect observation

引用本文复制引用

吕述华..门冬氨酸鸟氨酸治疗肝性脑病40例疗效观察[J].中国医学创新,2013,(32):118-119,2.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文